 Connection
Eric Simoes to Hospitalization
This is a "connection" page, showing publications Eric Simoes has written about Hospitalization.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.083 |
|
|
|
-
Stensballe LG, Ravn H, Kristensen K, Meakins T, Aaby P, Simoes EA. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. J Pediatr. 2009 Feb; 154(2):296-8.
Score: 0.180
-
Stensballe LG, Hjuler T, Andersen A, Kaltoft M, Ravn H, Aaby P, Simoes EA. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study. Clin Infect Dis. 2008 Apr 15; 46(8):1165-71.
Score: 0.170
-
Choudhuri JA, Ogden LG, Ruttenber AJ, Thomas DS, Todd JK, Simoes EA. Effect of altitude on hospitalizations for respiratory syncytial virus infection. Pediatrics. 2006 Feb; 117(2):349-56.
Score: 0.146
-
Leidy NK, Margolis MK, Marcin JP, Flynn JA, Frankel LR, Johnson S, Langkamp D, Simoes EA. The impact of severe respiratory syncytial virus on the child, caregiver, and family during hospitalization and recovery. Pediatrics. 2005 Jun; 115(6):1536-46.
Score: 0.139
-
Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20.
Score: 0.119
-
Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, Polack FP, Balsells E, Acacio S, Aguayo C, Alassani I, Ali A, Antonio M, Awasthi S, Awori JO, Azziz-Baumgartner E, Baggett HC, Baillie VL, Balmaseda A, Barahona A, Basnet S, Bassat Q, Basualdo W, Bigogo G, Bont L, Breiman RF, Brooks WA, Broor S, Bruce N, Bruden D, Buchy P, Campbell S, Carosone-Link P, Chadha M, Chipeta J, Chou M, Clara W, Cohen C, de Cuellar E, Dang DA, Dash-Yandag B, Deloria-Knoll M, Dherani M, Eap T, Ebruke BE, Echavarria M, de Freitas L?zaro Emediato CC, Fasce RA, Feikin DR, Feng L, Gentile A, Gordon A, Goswami D, Goyet S, Groome M, Halasa N, Hirve S, Homaira N, Howie SRC, Jara J, Jroundi I, Kartasasmita CB, Khuri-Bulos N, Kotloff KL, Krishnan A, Libster R, Lopez O, Lucero MG, Lucion F, Lupisan SP, Marcone DN, McCracken JP, Mejia M, Moisi JC, Montgomery JM, Moore DP, Moraleda C, Moyes J, Munywoki P, Mutyara K, Nicol MP, Nokes DJ, Nymadawa P, da Costa Oliveira MT, Oshitani H, Pandey N, Paranhos-Baccal? G, Phillips LN, Picot VS, Rahman M, Rakoto-Andrianarivelo M, Rasmussen ZA, Rath BA, Robinson A, Romero C, Russomando G, Salimi V, Sawatwong P, Scheltema N, Schweiger B, Scott JAG, Seidenberg P, Shen K, Singleton R, Sotomayor V, Strand TA, Sutanto A, Sylla M, Tapia MD, Thamthitiwat S, Thomas ED, Tokarz R, Turner C, Venter M, Waicharoen S, Wang J, Watthanaworawit W, Yoshida LM, Yu H, Zar HJ, Campbell H, Nair H. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017 Sep 02; 390(10098):946-958.
Score: 0.081
-
Simoes EA, Groothuis JR, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick LM, Kimpen JL. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr. 2007 Jul; 151(1):34-42, 42.e1.
Score: 0.040
-
Stensballe LG, Kristensen K, Simoes EA, Jensen H, Nielsen J, Benn CS, Aaby P. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study. Pediatrics. 2006 Nov; 118(5):e1360-8.
Score: 0.038
-
Feltes TF, Simoes E. Palivizumab prophylaxis in haemodynamically significant congenital heart disease. Arch Dis Child. 2005 Aug; 90(8):875-7; author reply 875-7.
Score: 0.035
-
Nesselroth D, Yakub Hana H, Gleyzer A, Simoes EAF, Abu Atta M, Ben Yehuda Y, Bibi H, Somekh I, Somekh E. Comparison of the medical burden of COVID-19 with seasonal influenza and measles outbreaks. Acta Paediatr. 2022 03; 111(3):595-601.
Score: 0.027
-
Simoes EA. Overlap between respiratory syncytial virus infection and influenza. Lancet. 2001 Oct 27; 358(9291):1382-3.
Score: 0.027
-
Groothuis JR, King SJ, Hogerman DA, Paradiso PR, Simoes EA. Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia. J Infect Dis. 1998 Feb; 177(2):467-9.
Score: 0.021
-
Simoes EA, King SJ, Lehr MV, Groothuis JR. Preterm twins and triplets. A high-risk group for severe respiratory syncytial virus infection. Am J Dis Child. 1993 Mar; 147(3):303-6.
Score: 0.015
-
Puumalainen T, Quiambao B, Abucejo-Ladesma E, Lupisan S, Heiskanen-Kosma T, Ruutu P, Lucero MG, Nohynek H, Simoes EA, Riley I. Clinical case review: a method to improve identification of true clinical and radiographic pneumonia in children meeting the World Health Organization definition for pneumonia. BMC Infect Dis. 2008 Jul 21; 8:95.
Score: 0.011
-
Lupisan SP, Ruutu P, Erma Abucejo-Ladesma P, Quiambao BP, Gozum L, Sombrero LT, Romano V, Herva E, Riley I, Simoes EA. Predictors of death from severe pneumonia among children 2-59 months old hospitalized in Bohol, Philippines: implications for referral criteria at a first-level health facility. Trop Med Int Health. 2007 Aug; 12(8):962-71.
Score: 0.010
-
Lupisan SP, Ruutu P, Abucejo-Ladesma PE, Quiambao BP, Gozum L, Sombrero LT, Romano V, Riley I, Simoes EA. Central nervous system infection is an important cause of death in underfives hospitalised with World Health Organization (WHO) defined severe and very severe pneumonia. Vaccine. 2007 Mar 22; 25(13):2437-44.
Score: 0.010
-
Rodriguez WJ, Gruber WC, Groothuis JR, Simoes EA, Rosas AJ, Lepow M, Kramer A, Hemming V. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics. 1997 Dec; 100(6):937-42.
Score: 0.005
-
Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1997 Mar; 99(3):454-61.
Score: 0.005
-
Rodriguez WJ, Hall CB, Welliver R, Simoes EA, Ryan ME, Stutman H, Johnson G, Van Dyke R, Groothuis JR, Arrobio J, et al. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial. J Pediatr. 1994 Jul; 125(1):129-35.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|